Cel Research and development of a new microcapsule contrast agent with unique properties for MRI of both, the blood pool and internal organs. This dual agent approach allows patients to receive quicker and more convenient diagnosis, earlier disease detection and significantly reduces health care spending. The current problem relates to multiple and cost-& time intensive diagnosis - intended to be reduced to a 'one step diagnosis' by this new technology. Within the Craft project (step 2) we expect to develop a contrast agent suitable for the initial stages of clinical testing. Expertise and know-how of the Imaging market is available within the SME consortium. A suitable company (RTD performer) with the required know-how of the microcapsule spray dry technology is already identified. Dziedzina nauki engineering and technologymedical engineeringdiagnostic imagingmagnetic resonance imaging Program(-y) FP5-LIFE QUALITY - Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002 Temat(-y) 1.1.1.-3. - Key action The "Cell factory" Zaproszenie do składania wniosków Data not available System finansowania EAW - Exploratory awards Koordynator GOLDHAM BIOGLAN PHARMA GMBH Wkład UE Brak danych Adres Am Wasserberg 11 86441 ZUSMARSHAUSEN Niemcy Zobacz na mapie Koszt całkowity Brak danych Uczestnicy (1) Sortuj alfabetycznie Sortuj według wkładu UE Rozwiń wszystko Zwiń wszystko SANOCHEMIA PHARMAZEUTIKA AG Austria Wkład UE Brak danych Adres Boltzmanng-11 1090 WIEN Zobacz na mapie Koszt całkowity Brak danych